Association of aspirin use alone with mortality and liver-related events in MASLD: a multi-institutional three-year study
In this large cohort, daily aspirin use alone did not significantly reduce mortality or liver-related events in MASLD patients over three years. The observed trends may suggest potential long-term benefits, warranting further investigation into extended aspirin duration and combination strategies for MASLD management.
Authors
- Yu‐Tung Huang (ORCID: https://orcid.org/0000-0003-3224-7238)
- Chung‐Li Wang (ORCID: https://orcid.org/0000-0002-3364-8183)
- Victor Chien‐Chia Wu (ORCID: https://orcid.org/0000-0002-9918-4369)
- Yi‐Chung Hsieh (ORCID: https://orcid.org/0000-0002-1191-4399)
- Rong‐Nan Chien (ORCID: https://orcid.org/0000-0001-7656-4695)
- Chien‐Hao Huang (ORCID: https://orcid.org/0000-0003-1689-3221)
- Shang‐Hung Chang (ORCID: https://orcid.org/0000-0003-0462-2344)
- Zhen Zeng (ORCID: https://orcid.org/0000-0002-9702-197X)
- Chia‐Ling Wu (ORCID: https://orcid.org/0000-0002-0595-9064)
- Chao‐Wei Hsu
Institutions
- Memorial Hospital of South Bend (US)
- Chang Gung University (TW)
- Chang Gung Memorial Hospital (TW)
- Linkou Chang Gung Memorial Hospital (TW)
Publication Details
- Journal
- Annals of Medicine
- Published
- 2025-10-17
- DOI
- https://doi.org/10.1080/07853890.2025.2573146
- Citations
- 1
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.35